CXCL16 is a novel scavenger receptor on platelets and is associated with acute coronary syndrome

Peter Seizer; Konstantinos Stellos; Gerhard Selhorst; Björn F. Krämer; Michael R. Lang; Meinrad Gawaz; Andreas E. May

doi:10.1160/TH10-10-0689

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2011; 105(06): 1112-1114
DOI: 10.1160/TH10-10-0689

Letters to the Editor

Schattauer GmbH

CXCL16 is a novel scavenger receptor on platelets and is associated with acute coronary syndrome

Authors

Peter Seizer^*

¹Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, Eberhard-Karls University of Tuebingen, Germany
Konstantinos Stellos^*

¹Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, Eberhard-Karls University of Tuebingen, Germany
Gerhard Selhorst

¹Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, Eberhard-Karls University of Tuebingen, Germany
Björn F. Krämer

¹Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, Eberhard-Karls University of Tuebingen, Germany
Michael R. Lang

¹Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, Eberhard-Karls University of Tuebingen, Germany
Meinrad Gawaz

¹Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, Eberhard-Karls University of Tuebingen, Germany
Andreas E. May

¹Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, Eberhard-Karls University of Tuebingen, Germany

Abstract

Full Text

References

References
1 Seizer P, Gawaz M, May AE. Platelet-monocyte interactions--a dangerous liaison linking thrombosis, inflammation and atherosclerosis. Curr Med Chem 2008; 15: 1976-1980.
2 Siegel-Axel D, Daub K, Seizer P, Lindemann S. et al. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc Res 2008; 78: 8-17.
3 Shashkin P, Dragulev B, Ley K. Macrophage differentiation to foam cells. Curr Pharm Des 2005; 11: 3061-3072.
4 Seizer P, Schonberger T, Schott M. et al. EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation. Atherosclerosis 2010; 209: 51-57.
5 Chen M, Kakutani M, Naruko T. et al. Activation-dependent surface expression of LOX-1 in human platelets. Biochem Biophys Res Commun 2001; 282: 153-158.
6 Korporaal SJ, Van EM, Adelmeijer J. et al. Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A. Arterioscler Thromb Vasc Biol 2007; 27: 2476-2483.
7 Valiyaveettil M, Podrez EA. Platelet hyperreactivity, scavenger receptors and atherothrombosis. J Thromb Haemost 2009; 7 (Suppl. 01) 218-221.
8 Shimaoka T, Nakayama T, Fukumoto N. et al. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J Leukoc Biol 2004; 75: 267-274.
9 Shimaoka T, Kume N, Minami M. et al. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem 2000; 275: 40663-40666.
10 Matloubian M, David A, Engel S. et al. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 2000; 1: 298-304.
11 Ludwig A, Weber C. Transmembrane chemokines: versatile ‘special agents’ in vascular inflammation. Thromb Haemost 2007; 97: 694-703.
12 Yamauchi R, Tanaka M, Kume N. et al. Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease. Arterioscler Thromb Vasc Biol 2004; 24: 282-287.
13 Lehrke M, Millington SC, Lefterova M. et al. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans. J Am Coll Cardiol 2007; 49: 442-449.
14 Stellos K, Bigalke B, Stakos D. et al. Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication. J Thromb Haemost 2010; 8: 205-207.